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Abstract 10 
A study was carried out to investigate the combined effect of exogenous enzymes and 11 
probiotic supplementation on tilapia growth, intestinal morphology and microbiome 12 
composition. Tilapia (34.56 ± 0.05 g) were fed one of four diets (35% protein, 5% lipid); one 13 
of which was a control and the remaining three diets were supplemented with either enzymes 14 
(containing phytase, protease and xylanase), probiotic (containing Bacillus subtilis, B. 15 
licheniformis and B. pumilus) and enz-pro, the combination of the enzymes and probiotic. 16 
Tilapia fed diet supplemented with enz-pro performed better (P < 0.05) than tilapia fed the 17 
control and probiotic supplemented diets in terms of final body weight (FBW), specific 18 
growth rate (SGR), feed conversion ratio (FCR) and protein efficiency ratio (PER). The 19 
dietary treatments did not affect somatic indices. The serum lysozyme activity was 20 
significantly higher (P < 0.05) in tilapia fed the probiotic supplemented diet than of those fed 21 
the remaining experimental diets. The intestinal perimeter ratio was higher (P < 0.05) in 22 
tilapia fed enz-pro supplemented diet when compare to those fed with the control and 23 
probiotic supplemented diets. Goblet cells abundance, microvilli diameter and total 24 
enterocyte absorptive surface was higher (P < 0.05) in tilapia fed diet supplemented with 25 
enz-pro than those fed the control diet. High-throughput sequencing revealed that majority of 26 
reads derived from the tilapia digesta belonged to members of Fusobacteria (predominantly 27 
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Cetobacterium) distantly followed by Proteobacteria and Firmicutes. The alpha and beta 28 
diversities did not differ among dietary treatments indicating that the overall microbial 29 
community was not modified to a large extent by dietary treatment. In conclusion, 30 
supplementation of the diet with a combination of enzymes and probiotic is capable of 31 
improving tilapia growth and intestinal morphology without deleterious effect on the 32 
intestinal microbial composition. 33 
 34 
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1.0 Introduction 36 
The growth of aquaculture, the world’s fastest growing food production sector, is linked to 37 
population increases and consequently the intensification and diversification of aquaculture 38 
operations (Msangi et al., 2013). The rearing technologies for the intensive operations in 39 
aquaculture under poor management can be accompanied by sub-optimum environmental 40 
conditions as a result of overcrowding and overfeeding. These conditions may be stressful for 41 
fish, leading to decreased performance and subsequently compromised immune responses 42 
which leave fish prone to infection and disease by opportunistic pathogens. However, with 43 
the need to meet global animal protein demand and the growing pressure on fish farmers to 44 
reduce production cost without necessarily transferring the cost to the consumers, the 45 
stressful conditions associated with the intensive aquaculture operation is likely to continue in 46 
many parts of the world. The growing concept of immune-nutrition (production of high 47 
quality feed with optimal growth and immune boosting effects) could be of benefit to 48 
intensive aquaculture operation (Nakagawa et al., 2007, Kiron, 2012). 49 
The gastro-intestinal (GI) microbiota of fish has been reported to play a key role in nutrition 50 
and immunity. According to Nayak (2010), GI microbiota are involved in major nutritional 51 
functions which include digestion, nutrient utilisation and the production of specific amino 52 
acids, enzymes, short-chain fatty acids, vitamins and mineral availability. The nutritional role 53 
of GI microbiota includes the production of vitamins and the secretion of digestive enzymes 54 
that promote nutrient digestion as well as synthesise nutrients and metabolites required by 55 
fish (Okutani et al., 1967, Saha et al., 2006, Li et al., 2010, Liu et al., 2016). In addition, GI 56 
microbiota are capable of influencing immune status, disease resistance, survival, feed 57 
utilisation and may have a role in preventing pathogens from colonising the host (Denev et al., 58 
2009, Ringø et al., 2015). Apart from nutrition and immunological effects, fish GI microbiota 59 
  
have important functions in host metabolism, mucosal development and promote gut 60 
maturation (Bates et al., 2006, Rawls et al., 2004, Round and Mazmanian, 2009). 61 
It is well established that GI microbial communities are sensitive to rearing environment, 62 
seasonal and diet changes including the supplementation with probiotic (Dimitroglou et al., 63 
2011, Merrifield et al., 2010, Romero et al., 2014) and exogenous digestive enzymes 64 
(Bedford and Cowieson, 2012, Geraylou et al., 2012, Zhou et al., 2013, Jiang et al., 2014, 65 
Adeoye et al., 2016, Hu et al., 2016). Research into the use of exogenous digestive enzyme 66 
and probiotic supplements is increasing since aquafeed manufacturers are increasingly 67 
interested in producing ‘functional and environmentally friendly aquafeeds’. The potential 68 
effects of exogenous digestive enzymes (Kumar et al., 2012, Castillo and Gatlin, 2015, 69 
Lemos and Tacon, 2016) and probiotic (Pérez‐Sánchez et al., 2014) on fish have been 70 
reviewed as individual supplement. To the authors’ understanding, there is no previous report 71 
on combined used of exogenous digestive enzymes and probiotic as supplement in fish. 72 
However, the combined supplementation of exogenous enzymes and probiotic could result in 73 
a complimentary mode of actions: ability to produce fibre-degrading enzymes by probiotic 74 
may complement endogenous enzyme activity. On the other hand, exogenous digestive 75 
enzymes may increase availability of suitable substrate for probiotic as well as promote the 76 
growth of other beneficial bacteria (GI microbiota). 77 
Given the potential complimentary mode of actions of exogenous digestive enzymes and 78 
probiotic, the two products could improve the growth performance and health status of 79 
farmed fish when fed diets supplemented with both the enzymes and probiotic as a cocktail; 80 
Nile tilapia (Nile tilapia) is an important freshwater fish species of considerable economic 81 
value globally. Therefore, the objective of this study was to evaluate the combined effects of 82 
exogenous digestive enzymes and probiotic on growth, intestinal morphology and 83 
microbiome composition of Nile tilapia. 84 
  
2.0 Materials and methods 85 
2.1 Experimental design and diets preparation 86 
All experimental work involving fish was in accordance with the principles of the Animals 87 
(Scientific Procedures) Act 1986 and the Plymouth University Ethical Committee. 88 
The trial was conducted in a flow – through aquaculture system in King Mongkut’s Institute 89 
of Technology Ladkrabang - Thailand (KMITL). The flow – through system contains 12 90 
square concrete tanks (508 L capacity each) and were supplied with freshwater sourced from 91 
a local river system. Three hundred and sixty all male Nile tilapia (Oreochromis niloticus) of 92 
mean weight 34.56 ± 0.05 g obtained from Charoen Pokphand farm in Thailand were 93 
randomly distributed (30 fish per tank) into the 12 tanks after two weeks of acclimatization. 94 
The photoperiod and water temperature (30.34±0.15 °C) was maintained at ambient condition. 95 
The water pH (6.20±0.22) and dissolved oxygen levels (>5.0 mg L
-1
) were monitored daily 96 
using a HQ40d pH meter and dissolved oxygen multi-parameter meter (HACH Company, 97 
Loveland, USA). NH3 (0.304±0.08 mg L
-1
), NO
2-
 (0.016±0.002 mg L
-1
) and NO
3-
 (1.46±0.19 98 
mg L
-1
) were also monitored on a weekly basis using a nutrient analyser (SEAL AQ2 99 
Analyser, Hampshire, UK). A constant water flow of 4.9 L min
-1
 (per tank) was used during 100 
the experiment to maintain the water quality and ensure optimum conditions for the fish.  101 
A commercial diet (No. 461; 35% protein, 5% lipid) was obtained from INTEQC Feed Co. 102 
Ltd., Thailand and was used as basal formulation. The commercial diet was ground in a 103 
blender to powder and sieved to remove large particles. An enzyme cocktail (containing 104 
phytase, protease and xylanase), Sanolife PRO-F (a mixture of Bacillus subtilis, B. 105 
licheniformis and B. pumilus) and a combination of the enzyme cocktail and Sanolife PRO-F 106 
were added to the diets separately as stated in Table 1. The diets were coded as control (zero 107 
supplementation), enzymes (phytase, protease and xylanase supplementation), probiotic 108 
  
(probiotic supplementation) and enz-pro (enzymes and probiotic supplementation as a 109 
cocktail). The diets were mixed thoroughly for 15 min to ensure homogeneity. Warm water 110 
was added to form a consistency suitable for subsequent cold press extrusion. Afterwards, the 111 
diets were dried in an air convection oven set at 45 °C for 24 h. The basal diet served as the 112 
control and was prepared in the same way as those supplemented with the enzyme cocktail 113 
and probiotic, with the exception of the supplementation. Tilapia were fed the experimental 114 
diets for seven weeks at 3 % biomass day
-1
 in three equal rations. Daily feed was adjusted on 115 
a weekly basis by batch weighing following a 24 h deprivation period. 116 
2.2 Growth performance, feed utilisation and somatic indices 117 
Growth performance, feed utilisation and somatic indices were assessed by final body weight 118 
(FBW), specific growth rate (SGR), feed conversion ratio (FCR), protein efficiency ratio 119 
(PER), hepatosomatic index (HSI), viscero-somatic index (VSI) and condition factor (K), 120 
Calculations were carried out using the following formulae:                                          121 
SGR = 100 ((ln FBW – ln IBW)/T), where FBW = final body weight (g) and IBW = initial 122 
body weight (g)  123 
FCR = FI/WG, where FI = feed intake (g) and WG = wet weight gain (g) 124 
PER = WG/PI, where WG = wet weight gain (g) and PI = protein ingested (g), 125 
K = (100 x FW)/ FL
3
, where FL = FL = final length (cm)  126 
HSI = 100 (LW/ FBW), where LW = liver weight (g) and FBW = final body weight (g) 127 
VSI = 100 (VW/ FBW), where VW = visceral weight (g) 128 
All fish were euthanized with buffered tricaine methanesulfonate, MS222 (Pharmaq Ltd. 129 
Hampshire, UK) at a concentration of 200 mg L
-1
 followed by destruction of the brain prior 130 
to sampling. For proximate composition analysis (AOAC, 1995), at the onset of the trial 12 131 
  
fish were pooled to constitute three samples; at the end of the trial, three fish per tank were 132 
sampled. The fish were also used to record viscera weight and whole body weight in order to 133 
calculate the HSI and VSI. 134 
2.3 Haemato – immunological parameters 135 
At the end of the feeding trial, blood from three fish per tank (n = 9) was taken from the 136 
caudal arch using a 25 gauge needle and a 1 mL syringe after fish were anaesthetized with 137 
MS222 (Pharmaq Ltd. Hampshire, UK) at 150 mg L
-1
. Blood smears were prepared for 138 
determination of differential leucocyte counts and additional blood was left to clot for a 139 
period of 12 h (at 4°C) to isolate serum. Serum was isolated by centrifugation at 3600 g for 5 140 
min and was stored at −80 °C until further analysis. Haematocrit (measured and read as % 141 
packed cell volume; PCV), haemoglobin, red blood cells (RBC), serum lysozyme activity, 142 
white blood cells (WBC) and differential leucocyte proportions were determined according to 143 
standard methods as described by Rawling et al. (2009). 144 
2.4 Intestinal histology 145 
At the end of the trial, three fish per tank were sampled for histological appraisal (light, 146 
scanning electron and transmission electron microscopy) of the mid-intestine (n = 9). For 147 
light microscopy examination, the samples were fixed in 10% formalin, dehydrated in graded 148 
ethanol concentrations and embedded in paraffin wax. In each specimen, multiple sets of 149 
sections (5 mm thick) were stained with May-Grünwald Giemsa (MGG), haematoxylin and 150 
eosin (H&E) and Alcian-Blue-PAS (Dimitroglou et al., 2010, Ferguson et al., 2010). The 151 
intestinal perimeter ratios (arbitrary units, AU) were assessed after Dimitroglou et al. (2009) 152 
and the numbers of intraepithelial leucocytes (IELs) and goblet cells in the epithelium, across 153 
a standardized distance of 100 µm (10 folds per specimen), was then calculated by averaging 154 
the cell numbers from all specimens (Ferguson et al., 2010). For scanning electron 155 
  
microscopy (SEM) and transmission electron microscopy (TEM), samples were washed in 1 % 156 
S-carboxymethyl-L-cysteine for 30 seconds (SEM only) to remove mucus before fixing in 157 
2.5 % glutaraldehyde in sodium cacodylate buffer (0.1 M pH 7.2). samples were processed as 158 
described elsewhere (Dimitroglou et al., 2009) and screened with a JSM 6610 LV (Jeol, 159 
Tokyo, Japan) SEM or JEN 1400 (Jeol, Tokyo, Japan) TEM. The SEM images were analysed 160 
to assess microvilli count per µm
2
 (MCVT) and enterocyte apical area (EAA), µm
2
. The 161 
TEM images were analysed for microvilli length and diameter. All images were analysed 162 
with ImageJ version 1.47 (National Institute of Health, USA). 163 
Enterocyte total absorptive surface (ETAS), µm
2
 was calculated according to the following: 164 
ETAS = ((2π x ½ MVD x MVL) + (π x ½ MVD2)) x MVCT x EAA 165 
Where ETAS = enterocyte total absorptive surface (µm
2
); π = pie constant = 22/7; MVD = 166 
microvilli diameter (µm); MVL = microvilli length (µm); MVCT = microvilli count (No. 167 
/µm
2
); and EAA = enterocyte apical area. 168 
2.5 Intestinal microbiology 169 
The GI tract was aseptically removed and faecal matter from the mid-intestine was isolated 170 
and processed on an individual fish basis. DNA was extracted from 100 mg faecal matter 171 
after lysozyme (50 mg mL
-1 
in TE buffer) incubation for 30 min at 37 °C using PowerFecal
®
 172 
DNA Isolation Kit according to the manufacturer’s instructions. 173 
2.5.1 High-throughput sequencing analysis 174 
DNA extractions from the faecal matter were prepared for high-throughput sequencing as 175 
described by Standen et al. (2015).  In brief, PCR amplification of the 16S rRNA V1-V2 176 
region was conducted using primers 27F (5′-AGA GTT TGA TCM TGG CTC AG-3′) 177 
and 338R (5′-GCW GCC WCC CGT AGG WGT-3′). Each PCR contain 0.5 µL primer 178 
  
27F and 338R  (50pmol µL-1; Eurofins MWG, Germany), 25 µL MyTaq™  Red Mix 179 
(Bioline), 22 µL molecular grade water (Ambion) and 2 µL DNA template. Thermal cycling 180 
was conducted using a TC-512 thermal cycler (Techne, Staffordshire, UK) under the 181 
following conditions: initial denaturation at 94 °C for 7 minutes, then 10 cycles at 94 °C for 182 
30 seconds, touchdown of 1 °C per cycle from 62-53 °C for 30 seconds and 72 °C for 30 183 
seconds. Furthermore, 20 cycles were performed at 94 °C for 30 seconds, 53 °C for 30 184 
seconds and 72 °C for 30 seconds before a final extension for 7 minutes at 72 °C. The quality 185 
of the PCR products was checked using agarose gel electrophoresis. PCR products were 186 
purified (QIAquick PCR Purification Kit; Qiagen) and quantified using a Qubit
®
 2.0 187 
Fluorometer (Invitrogen). Before sequencing, the amplicons were assessed for fragment 188 
concentration using an Ion Library Quantitation Kit (Life Technologies TM, USA), the 189 
concentrations were then adjusted to 26 pM. Amplicons were attached to Ion Sphere Particles 190 
using Ion PGM Template OT2 400 kit (Life Technologies™, USA) according to the 191 
manufacturer’s instructions. Multiplexed sequencing was conducted using Ion Xpress 192 
Barcode Adapters (Life Technologies™) and a 318™ chip (Life Technologies™) on an Ion 193 
Torrent Personal Genome Machine (Life Technologies™). The sequences were binned by 194 
sample and filtered within the PGM software to remove low quality reads. Data were 195 
exported as FastQ files. 196 
Phylogenetic analyses were performed after the removal of reads with low quality scores (Q 197 
< 20) with FASTX-Toolkit (Hannon Laboratory, USA). Sequences were concatenated and 198 
sorted by sequence similarity into a single fasta file, denoised and analysed using the QIIME 199 
1.8.0 pipeline (Caporaso et al., 2010b). The USEARCH quality filter pipeline (Edgar, 2010) 200 
was used to filter out putative chimeras and noisy sequences and carry out OTU picking on 201 
the remaining sequences. The taxonomic affiliation of each OTU was determined based on 202 
the Greengenes database (DeSantis et al., 2006) using the RDP classifier (Wang et al., 2007) 203 
  
clustering the sequences at 95 % similarity with a 0.80 confidence threshold and a minimum 204 
sequence length of 150 base pairs. Non-chimeric OTUs were identified with a minimum 205 
pairwise identity of 95 %, and representative sequences from the OTUs were aligned using 206 
PyNAST (Caporaso et al., 2010a). To estimate bacterial diversity, the number of OTUs 207 
present in the samples was determined and a rarefaction analysis was performed by plotting 208 
the number of observed OTUs against the number of sequences. Good’s coverage, Shannon-209 
Wiener (diversity) and Chao1 (richness) indices were calculated. The similarities between the 210 
microbiota compositions of the intestinal samples were compared using weighted principal 211 
coordinate analysis (PCoA) and unweighted pair group method with arithmetic mean 212 
(UPGMA). 213 
2.7 Statistical analysis 214 
All data are presented as mean ± standard deviation. Statistical analysis (except high-215 
throughput sequencing) was carried out using SPSS for Windows (SPSS Inc., 22.0, Chicago, 216 
IL, USA). Data were checked for normality and equality of variance using Kolmogorov-217 
Smirnov and Bartlett’s test, respectively. Where normal assumptions were met, data were 218 
analysed using one-way analysis of variance (ANOVA) followed by a post-hoc Duncan test 219 
to determine significant differences. Where data violated these conditions after log 220 
transformation, a Kruskal- Wallis test was used. Differences between treatments were then 221 
determined using a Mann-Whitney U-test. For high-throughput sequence data, a Kruskal-222 
Wallis test was performed followed by pairwise comparison to compare alpha diversity 223 
metrics, and Vegan and ape packages of R were used to analyse the beta diversity of the 224 
groups. STAMP v2.1.3 and PRIMER V7 software (PRIMER-E Ltd., Ivybridge, UK) were 225 
used to distinguish differences at each taxonomic level for high-throughput sequence data. In 226 
all cases significance was accepted at P < 0.05. 227 
  
3.0 Results 228 
3.1 Growth performance, feed utilisation and somatic indices 229 
Growth performance and feed utilisation was assessed using tilapia FBW, SGR, FCR and 230 
PER (Table 2). Tilapia fed the diet supplemented with enz-pro performed better (P < 0.05) 231 
than tilapia fed the control and probiotic supplemented diets in term of FBW, SGR, FCR and 232 
PER. However, there was no difference (P > 0.05) in the performance of tilapia fed the diet 233 
supplemented with the enzymes and those fed diet supplemented with enz-pro in terms of 234 
FBW, SGR and FCR. The dietary treatment did not have a significant effect on the tilapia 235 
somatic indices. A 100% survival was recorded in all the treatments.  236 
3.2 Haemato – immunological parameters  237 
The haemato-immunological parameters of tilapia fed the experimental diets are displayed in 238 
Table 3. Serum lysozyme activity was significantly higher (P < 0.05) in tilapia fed the 239 
probiotic supplemented diet compared to serum lysozyme activity in tilapia fed the control 240 
and enz-pro treatments. No differences were observed between treatments in any other 241 
haematological parameter measured. 242 
3.3 Intestinal histology 243 
The mid-intestine of tilapia fed each of the experimental diets was examined by light 244 
microscopy (Figure 1), scanning and transmission electron microscopy (Figure  2). Tilapia 245 
from all treatments showed intact epithelial barriers with extensive mucosal folds extending 246 
into the lumen. Each fold consisted of simple lamina propria with abundant IELs and goblet 247 
cells (Figure  1). Tilapia fed the diet supplemented with enz-pro had significantly higher 248 
perimeter ratio and microvilli count (density) compared to tilapia fed probiotic supplemented 249 
and control diets (Table  4). Goblet cells abundance was significantly higher (P < 0.05) in 250 
tilapia fed the diet supplemented with enz-pro than those fed the control diet. Microvilli 251 
  
diameter of tilapia fed a diet supplemented with enz-pro was larger (P < 0.05) than tilapia fed 252 
the control diet. This translated to higher (P < 0.05) enterocyte absorptive area in tilapia fed 253 
diets supplemented with enzymes and a combination of both enzymes and probiotic than 254 
tilapia fed with the control diet. 255 
3.4 Intestinal microbiology 256 
A total of 536,602 sequence reads from the tilapia digesta were retained after trimming; after 257 
removing low quality reads, 24,521±14,451, 25,588±12,901, 32,708±10,388 and 258 
24,503±12,255 sequences for control, enzymes, probiotic and enz-pro treatments, 259 
respectively, were used for downstream analyses. Good’s coverage rarefaction curves for the 260 
treatments reached a plateau close to 1 (0.9994 – 0.9996) (Figure  3a and Table  5), an 261 
indication that sufficient coverage was achieved and that the OTUs detected in the samples 262 
are representative of the sampled population. 263 
The majority of reads derived from the tilapia digesta belonged to members of Fusobacteria (> 264 
89%) distantly followed by Proteobacteria (> 7%) and Firmicutes (> 0.4%) (Figure  3c). 265 
Table  6 shows the most abundant genera in tilapia digesta. Cetobacterium, Aquaspirillum, 266 
Edwardsiella and Plesiomonas as well as unknown genera from the order Clostridiales, 267 
family Clostridiaceae, class Gammaproteobacteria and order Aeromonadales were present in 268 
all treatments with Cetobacterium being dominant (> 84%) in all treatments. Cetobacterium 269 
accounted for 92.1%, 89.3%, 84.2% and 91% 16S rRNA reads in tilapia fed the control, 270 
enzymes, probiotic and enz-pro diets, respectively. Unknown genera from the families 271 
Leuconostocaceae and Methylocystaceae were present in the control, enzymes and probiotic 272 
treatments but absent in the enz-pro treatment. Weissella and an unknown genus from the 273 
family Methylocystaceae were present in the enzymes and probiotic treatments. Balneimonas 274 
was present in enzymes and enz-pro treatments. An unknown genus from the class 275 
  
Betaproteobacteria was also present in the control, probiotic and enz-pro treatments. 276 
However, Corynebacterium, Bacillus, Staphylococcus and Rhodobacter were only detected in 277 
probiotic treatment. 278 
The alpha diversity parameters are presented in Table  5. There was no significant difference 279 
between the treatments for the alpha diversity metrics assessed.  Figure  3b shows the beta 280 
diversity of the digesta through PCoA plots (based on Bray-Curtis dissimilarity matrix). The 281 
PCoA plot shows a spatial differentiation among the treatments. 282 
4.0 Discussion 283 
The previous reports on the use of exogenous digestive enzymes (Cao et al., 2007, Kumar et 284 
al., 2012, Castillo and Gatlin, 2015, Lemos and Tacon, 2016) and probiotic (Pandiyan et al., 285 
2013, Pérez‐Sánchez et al., 2014) as individual supplement in fish diet abounds. However, 286 
to the authors’ knowledge no research has been conducted previously on the combined 287 
effects of exogenous digestive enzymes and probiotic on growth, intestinal morphology and 288 
microbiome of Nile tilapia. In this study, Nile tilapia were fed diets supplemented with 289 
enzymes, probiotic and a combination of both the enzymes and probiotic. Given the potential 290 
complimentary modes of actions of exogenous digestive enzymes and probiotic, the two 291 
products (when used in combination) could offer more benefits than when used alone. This is 292 
confirmed in this study with improved growth performance in terms of FBW, SGR, FCR and 293 
PER observed in tilapia fed diet supplemented with enz-pro a combination of enzymes and 294 
probiotic. The enhanced growth performance could be attributed to the ability of probiotic to 295 
produce fibre-degrading enzymes that may complement endogenous enzyme activity for 296 
digestion in fish (Roy et al., 2009, Ray et al., 2010, Ray et al., 2012) as well as the external 297 
exogenous enzyme capacity to increase the availability of suitable substrates for probiotic 298 
action (Bedford and Cowieson, 2012). In addition, the enzymes could positively affect the gut 299 
  
microbiota through improved digestibility and enhanced nutrient absorption and assimilation. 300 
The indigestible NSPs and trypsin inhibitors that appear to induce necrotic enteritis in certain 301 
fish species are well known substrates for xylanase and protease enzymes respectively. 302 
Furthermore, xylanase may increase the digestion of NSPs (e.g. arabinoxylans) which could 303 
provide substrates for utilisation by gut bacteria (Bedford, 2000). 304 
The use of enzymes and probiotic as individual supplements in this study did not have 305 
significant effects on the growth performance of tilapia. This is somewhat contrary to the 306 
results of Hlophe‐Ginindza et al. (2015) who observed significantly improved growth 307 
performance in tilapia (Oreochromis mossambicus) when an exogenous enzyme cocktail, 308 
Natuzyme
®
 (containing protease, lipase, α-amylase, cellulase, amyloglucosidase, β-glucanase, 309 
pentosonase, hemicellulose, xylanase, pectinase, acid phosphatase and acid phytase) was 310 
added to a plant-based diet. The inconsistency in the findings may be due to lower application 311 
dosage of enzymes (75 mg kg
-1
 phytase, 300 mg kg
-1
 protease and 250 mg kg
-1
 xylanase) 312 
used in the current study compared to 500 mg kg
-1 
used by Hlophe‐Ginindza et al. (2015), 313 
the broader diversity of enzymes in Natuzyme
® 
or the different tilapia species. On the other 314 
hand, the lack of effect on tilapia growth fed probiotic supplemented diet in the current study 315 
is similar to the findings of Ng et al. (2014) who reported that dietary probiotic (B. subtilis, B. 316 
licheniformis or Pediococcus sp.) had no effect on growth or feeding efficiencies of tilapia. 317 
Shelby et al. (2006) also observed a non-effect of dietary Enterococcus faecium and 318 
Pediococcus acidilactici or mixtures of B. subtilis and B. licheniformis on growth of tilapia. 319 
However, B. subtilis when used solely as a dietary supplement was reported to be an effective 320 
growth promoter in tilapia (Aly et al., 2008), yellow croaker, Larimichthys crocea (Ai et al., 321 
2011) and rohu, Labeo rohita (Nayak and Mukherjee, 2011). 322 
  
The improvement in intestinal morphology in the current study could be the result of 323 
complimentary changes to meet the increased rates of digestion and absorption after exposure 324 
to the diets. In this study, tilapia fed the diet supplemented with probiotic and enzymes 325 
presented a higher perimeter ratio, microvilli count (density) and larger diameter which 326 
translated to increased enterocyte absorptive area and subsequently resulted in the improved 327 
growth performance when compared with tilapia fed the control diet. This could be attributed 328 
to the combined effect of enzymes and probiotic to confer a superior beneficial effect than 329 
when used alone. However, there was no significant difference between intestinal histology 330 
of tilapia fed the control and probiotic supplemented diets. This is contrary to Standen et al. 331 
(2015) who reported increased population of IELs, a higher absorptive surface area index and 332 
higher microvilli density in the intestine of tilapia fed a diet supplemented with AquaStar® 333 
Growout, a multi-species probiotic containing Lactobacillus reuteri, Bacillus subtilis, 334 
Enterococcus faecium and Pediococcus acidilactici. This difference could be attributed to 335 
different probiotic composition as well as application dosage which is 20 mg kg
-1
 in the 336 
present study compared to 5 g kg
-1
 used by Standen et al. (2015). 337 
In this study, the dietary treatment did not have significant effect on the tilapia 338 
haematological parameters. Emadinia et al. (2014) also reported that supplementation of 339 
poultry diets with an enzyme cocktail (xylanase, β-glucanase, cellulase, pectinase, phytase, 340 
protease, lipase, and α-amylase) had no effects on haemato-immunological parameters. 341 
However, in the present study the serum lysozyme activity was significantly higher in tilapia 342 
fed the probiotic supplemented diet compared to those fed the control and enz-pro 343 
supplemented diets respectively. This is similar to the findings of Mandiki et al. (2011) who 344 
reported that dietary Bacillus probiotic have a stimulating effect on lysozyme activity in 345 
Eurasian perch, Perca fluviatilis. Standen et al. (2013) also reported that dietary probiotic are 346 
able to stimulate innate immune response in tilapia. 347 
  
Gut microbiota may function to prevent pathogens from colonization of the intestinal tract. 348 
The importance of commensal gut microbiota is highly important for normal functioning of 349 
the immune apparatus of the GI tract in fish (Rawls et al., 2004, Pérez et al., 2010, Ringø et 350 
al., 2015). The population size and composition of intestinal microbiota could influence the 351 
extent of nutrient digestion and absorption by the host (Merrifield et al., 2010, Dimitroglou et 352 
al., 2011, Bedford and Cowieson, 2012, Ray et al., 2012). In addition, GI microbiota are 353 
understood to influence disease resistance, development, survival and feed utilisation (Denev 354 
et al., 2009). Jiang et al. (2014) reported that dietary supplementation of xylanase affected the 355 
abundance of Lactobacillus, Escherichia coli and Aeromonas in the intestine of juvenile Jian 356 
carp. The intestinal microbiota of grass carp fed dietary cellulase changed in respect to 357 
bacteria species and density (Zhou et al., 2013). Adeoye et al. (2016) also reported alteration 358 
in the intestinal bacterial community profile of tilapia fed carbohydrase supplemented diet. 359 
Similarly, several studies have reported the modulating effect of probiotic on fish GI 360 
microbiota (Dimitroglou et al., 2011, Pandiyan et al., 2013, Pérez‐Sánchez et al., 2014, 361 
Standen et al., 2015). However, in the present study exogenous enzymes and probiotic did not 362 
modify to a large extent microbial community of tilapia fed the experimental diets. 363 
Regardless of the dietary treatments, certain OTUs such as Clostridiales, Cetobacterium, 364 
Aquaspirillum, Gammaproteobacteria, Aeromonadales, Edwardsiella and Plesiomonas were 365 
found in the intestinal tract of tilapia, forming core microbiome. This is similar to findings by 366 
Larsen et al. (2014) who reported dominance of genus Cetobacterium in the gut of warm 367 
water fish species. Similarly, shared core gut microbiota was observed in zebrafish 368 
irrespective of geographical locations (Roeselers et al., 2011). Wong et al. (2013) also 369 
reported core intestinal microbiota in rainbow trout being resistant to variation in diet and 370 
rearing density. Similarly, the tilapia microbiome was quite stable and resistant to potential 371 
changes in community abundance and diversity in response to the dietary supplements used 372 
  
in this study. However, the functionality of the microbiome may have been altered and this 373 
may have contributed towards the improved performance of the tilapia fed the enzymes and 374 
probiotic cocktail. Future studies should include metagenomics and metatranscriptomics of 375 
the gut microbiome to investigate this hypothesis. 376 
In conclusion, supplementation of tilapia diets with a combination of enzymes and probiotic 377 
is capable of improving tilapia growth and intestinal histology without deleterious effect on 378 
the fish health or intestinal microbiota. It is pertinent therefore to consider these finding for 379 
the future development of diets specific for tilapia under a variety of culture conditions and 380 
stages of growth from fry to fingerlings and on-growing to production (harvest) size. 381 
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Tables 562 
Table 1. Dietary formulation and proximate composition (g kg
-1
) of experimental diets 563 
 Control Enzymes Probiotics Enz-pro 
Commercial feed
a
 1000 999.94 999.98 998.92 
Phytase
b 
(mg) 0 7.5 0 7.5 
Protease
c 
(mg) 0 30 0 30 
Xylanase
d 
(mg) 0 25 0 25 
Probiotics
e 
(mg) 0 0 20 20 
Total 1000 1000 1000 1000 
Proximate composition (% as fed basis) 
Moisture  8.03±0.04 6.87±0.14 8.06±0.06 6.63±0.09 
Protein  34.32±0.28 34.78±0.09 34.43±0.13 34.56±0.08 
Lipid  5.49±0.04 5.33±0.10 5.38±0.70 5.22±0.08 
Ash  13.13±0.11 13.13±0.17 13.16±0.04 13.4±0.04 
Energy (MJ kg
-1
) 17.06±0.00 17.56±0.1 17.31±0.4 17.66±2.1 
Fibre  3.65±0.06 3.15±0.12 3.15±0.07 3.21±0.05 
     
a
No. 461, INTEQC Feed Co Ltd., Thailand 564 
b
RONOZYME
®
 Hiphos (contains 10,000FYT g
-1
) from DSM Nutritional Products 565 
c
RONOZYME
®
 ProAct (contains 75,000 PROT g
-1
) from DSM Nutritional Products 566 
d
RONOZYME
®
 WX (contains 1000 FXU g
-1
) from DSM Nutritional Products 567 
e
Sanolife PRO-F (contains 1 x 10
10
 CFU g
-1  
B. subtilis, B. licheniformis and B. pumilus) from 568 
INVE Aquaculture 569 
  570 
  
Table 2. Growth performance, feed utilisation and somatic indices of tilapia fed the 571 
experimental diets 572 
 Control Enzymes Probiotics Enz-pro 
IBW (g fish
-1
) 34.5±0.18 34.54±0.05 34.6±0.13 34.61±0.29 
FBW (g fish
-1
) 138.04±2.44
a
 139.49±2.83
ab
 136.61±1.34
a
 143.42±3.06
b
 
SGR (% day
-1
) 3.30±0.05
a
 3.32±0.04
ab
 3.27±0.02
a
 3.38±0.04
b
 
FI (g fish
-1
) 92.24±0.92 92.83±1.22 92.35±0.27 93.00±1.39 
FCR 0.94±0.02
a
 0.93±0.02
ab
 0.96±0.02
a
 0.9±0.01
b
 
PER 2.49±0.06
ab
 2.53±0.06
b
 2.42±0.05
a
 2.63±0.02
c
 
HSI 3.19±0.23 3.18±0.26 2.86±0.46 3.10±0.02 
VSI 21.72±0.66 21.44±2.96 23.40±1.31 21.83±1.61 
K-factor 2.11±0.08 2.06±0.05 2.10±0.07 2.06±0.04 
Survival (%) 100 100 100 100 
Means in the same row with different superscripts are significantly different (P < 0.05). IBW, 573 
initial mean body weight; FI, daily feed intake; FBW, final mean body weight; SGR, specific 574 
growth rate; FCR, feed conversion ratio; PER, protein efficient ratio; HSI, hepatosomatic 575 
index and VSI, viscera-somatic index. 576 
 577 
 578 
 579 
  580 
  
Table 3. Haemato – immunological parameters of tilapia fed the experimental diets 581 
 Control Enzymes Probiotics Enz-pro 
Haematocrit, (%PCV) 40.11±3.34 39.11±1.35 41.67±3.48 39.66±1.53 
Haemoglobin, (g dL
-1
) 11.35±1.21 10.66±0.91 11.93±2.50 11.33±0.22 
RBC (10
6
 µL
-1
) 1.74±0.10 2.02±0.47 1.92±0.32 1.87±0.09 
RBC (10
3
 µL
-1
) 20.28±1.34 20.37±4.00 20.59±0.08 20.64±2.82 
MCV (fL) 232.53±12.95 207.97±36.80 223.30±34.69 213.04±12.66 
MCH (pg) 66.10±4.60 56.25±6.66 62.76±7.18 61.00±4.19 
MCHC (g dL
-1
) 28.29±1.59 27.25±1.59 28.75±3.98 28.62±0.97 
Lymphocytes (%) 90.43±2.57 91.40±2.38 91.77±1.30 89.43±3.54 
Monocytes (%) 5.14±1.87 4.26±2.06 3.94±0.54 5.74±1.97 
Granulocytes (%) 4.42±0.70 4.34±0.33 4.29±0.76 4.83±1.62 
Serum lysozyme (U) 115.31±22.87
a
 154.21±24.93
ab
 170.39±22.98
b
 127.97±6.43
a
 
Figures in each row with different superscript are significantly different (P < 0.05).  582 
RBC, red blood cells; WBC, leucocytes; MCV, mean corpuscular volume (haematocrit 583 
(%PCV) x 10)/RBC 106 µL
-1
); MCH, mean corpuscular haemoglobin (haemoglobin (g dL
-1
) 584 
x 10)/RBC (106 µL
-1
); MCHC, mean corpuscular haemoglobin concentration (haemoglobin 585 
(g dL
-1
) x 100)/haematocrit (%PCV); %, mean percentage of total leucocytes; U, lysozyme 586 
activity mL
-1 
min
-1
 587 
  588 
  
Table 4. Intestinal histology of tilapia fed the experimental diets 589 
    Control Enzymes Probiotics Enz-pro 
Perimeter ratio  5.30±0.7
a
 5.84±0.4
ab
 5.22±0.5
a
 6.72±0.8
b
 
Goblet cells (per 100µm) 3.85±0.6
a
 4.66±0.6
ab
 4.55±0.6
ab
 5.11±0.2
b
 
IELs (per 100µm) 29.16±5 29.48±2 29.85±5 28.68±4 
Microvilli count (per µm
2
)  91.82±4
a
 110.30±2.2
bc
 103.75±5.9
b
 115.17±6.5
c
 
Enterocyte apical area (µm
2
) 11.30±1.3 12.39±1.4 12.06±1 12.47±2.1 
Microvilli length (µm) 1.24±0.04 1.35±0.03 1.32±0.2 1.27±0.04 
Microvilli diameter (µm) 0.117±0.01
a
 0.123±0.01
ab
 0.123±0.01
ab
 0.130
b
 
ETAS(µm
2
) 499.9±82
a
 762.17±85
b
 674.55±145
ab
 773.7±151
b
 
Values with different superscripts indicate significant differences (P < 0.05). IELs, 590 
Intraepithelial leucocytes; ETAS = enterocyte total absorptive surface (µm
2
). 591 
 592 
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Table 5. Number  of reads, reads assigned to OTUs, Good’s coverage and alpha diversity indices of allochthonous intestinal microbiota 594 
composition between control, enzymes, probiotics and enz-pro treatments after 7 weeks of experimental feeding 595 
 Reads        
(pre-trimming) 
Reads assigned 
(post trimming) 
Good’s coverage Observed 
species 
Shanon’s 
diversity index 
Chao1 Index 
Control  41,748±22,108  24,521±14,451 0.9994±0.0001 75.90±9.54 2.82±0.10 92.00±11.19 
Enzymes 42,898±20,096 25,588±12,901 0.9995±0.0007 75.18±14.54 2.78±0.14 88.77±12.04 
Probiotics 57,638±15,492 32,708±10,388 0.9996±0.0002 76.95±17.94 3.20±0.60 87.28±16.15 
Enz-pro 40,244±18,342 24,503±12,255 0.9994±0.0001 72.12±7.10 2.94±0.25 88.04±8.18 
There were no significant differences between the treatments 596 
 597 
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Table 6. Abundance of the OTUs present in digesta samples (expressed as %). General level 599 
identification is presented where possible  600 
OTU Control Enzymes Probiotics Enz-Pro 
Cetobacterium 92.1±3.8 89.3±4.8 84.21±4.3 91.0±3.4 
Plesiomonas 4.0±2.5 7.7±4.4 5.6±1.9 4.0±2.2 
Unknown genus from order Aeromonadales 2.4±2.4 1.0±0.5 3.1±2.4 2.7±2.4 
Aquaspirillum 0.9±0.4 0.4±0.3 1.2±1.3 0.7±0.7 
Unknown genus from family Leuconostocaceae 0.1±0.1 0.2±0.3 1.5±2.9 0.0±0.0 
Unknown genus from family Leuconostocaceae 0.1±0.2 0.2±0.3 2.0±3.9 0.0±0.0 
Edwardsiella 0.2±0.1 0.6±0.7 1.2±1.4 0.3±0.1 
Unknown genus from order Clostridiales 0.1±0.1 0.2±0.1 0.1±0.0 0.1±0.1 
Unknown genus from family Clostridiaceae 0.1±0.1 0.1±0.1 0.1±0.1 0.1±0.1 
Unknown genus from class Gammaproteobacteria 0.1±0.0 0.1±0.1 0.3±0.2 0.1±0.1 
Unknown genus from class Betaproteobacteria 0.2±0.3 0.0±0.0 0.6±1.2 0.1±0.0 
Weissella 0.0±0.0 0.1±0.2 0.7±1.4 0.0±0.0 
Unknown genus from family Methylocystaceae 0.1±0.1 0.2±0.4 0.3±0.6 0.0±0.0 
Balneimonas 0.0±0.0 0.1±0.1 0.0±0.0 0.6±1.2 
Unknown genus from family Methylocystaceae 0.0±0.0 0.1±0.1 0.2±0.3 0.0±0.0 
Rhodobacter 0.0±0.0 0.0±0.0 0.4±0.9 0.0±0.0 
Leuconostoc 0.0±0.0 0.1±0.1 0.1±0.2 0.0±0.0 
Staphylococcus 0.0±0.0 0.0±0.0 0.2±0.4 0.0±0.0 
Corynebacterium 0.0±0.0 0.0±0.0 0.1±0.2 0.0±0.0 
Bacillus 0.0±0.0 0.0±0.0 0.1±0.2 0.0±0.0 
There was no significant difference across the treatments  601 
  
Figure legends 602 
Figure 1. Light micrograph of the mid-intestine of tilapia fed control (a & b), enzymes (c & 603 
d), probiotics (e & f) and enz-pro (g & h) diets. Goblet cells (arrows) and abundant IELs 604 
(arrowheads) are present in the epithelia. Abbreviations are E enterocytes, LP lamina propria 605 
and L lumen. Light microscopy staining: [a, c, e & g] H & E; [b, d, f & h] Alcian Blue-PAS. 606 
Scale bars = 100 µm. 607 
Figure ‎2. Scanning electron (a, c, e & g) and transmission electron (b, d, f & h) micrographs 608 
of the mid-intestine of tilapia fed control (a & b), enzymes (c & d), probiotics (e & f) and 609 
enz-pro (g & h) diets. Abbreviations are L lumen, TJ tight junction, MV microvilli. Scale 610 
bars = 1 µm (a, c, e & g), 2 µm (b, d, f & h). 611 
Figure 3. 16S rRNA V1-V2 high-throughput sequencing libraries of digesta from the tilapia 612 
intestine. (a) Good’s coverage rarefaction curves of the tilapia digesta; (b) PCoA plots using 613 
Bray-Curtis dissimilarity matrix where data points represent samples from tilapia fed a 614 
control diet (red triangles), enzymes diet (blue squares), probiotic diet (green triangles) and 615 
enz-pro diet (orange circles); and (c) proportion of 16S rRNA reads from the tilapia digesta 616 
by dietary treatment assigned at the phylum level. 617 
 618 
